PYRAZOLYL DERIVATIVES USEFUL AS ANTI-CANCER AGENTS
Download Read
Grantee
Novartis AG
Representative
Philippe Mueller
Application number
EP20829365B1
Kind
B1
Document number
4076662
Shortcuts
→Claims
→References by patents
→Other references

Classifications

PYRAZOLYL DERIVATIVES USEFUL AS ANTI-CANCER AGENTS

4076662 - EP20829365B1 - EPO

Application Dec 17, 2020 - Publication Jan 31, 2024

Simona COTESTA Marc GERSPACHER Catherine LEBLANC Bo LIU Edwige Liliane Jeanne LORTHIOIS Rainer MACHAUER Robert MAH Christophe MURA Pascal RIGOLLIER Nadine SCHNEIDER Stefan STUTZ Andrea VAUPEL Nicolas WARIN Rainer WILCKEN

Description

Claims

Patent References

Patent Publication Date Title
EP3539957A1 N/A N/A
WO2010/010154A1 N/A N/A
WO2012/016993A1 N/A N/A
WO2015/054572A1 N/A N/A
WO2019/099524A1 N/A N/A
WO2019/213516A1 N/A N/A
WO2019/217691A1 N/A N/A
WO2019/232419A1 N/A N/A
WO2006/084015A2 N/A N/A
WO2007/105058A2 N/A N/A
WO2009/016460A2 N/A N/A
CN108069955A N/A N/A
WO2014152588A N/A N/A
WO2017201161A N/A N/A
WO2018217651A N/A N/A
WO2018119183A N/A N/A

Other References

  • BRADLEY J NEWHOUSE ET AL: "Non-oxime pyrazole based inhibitors of B-Raf kinase", BIORGANIC & MEDICINAL CHEMISTRY LETTERS, ELSEVIER, AMSTERDAM , NL, vol. 21, no. 11, 6 December 2010 (2010-12-06), pages 3488-3492, XP028211510, ISSN: 0960-894X, DOI: 10.1016/J.BMCL.2010.12.038 [retrieved on 2010-12-17]
Back to top

Statistics

Seen <100 times
Downloaded <100 times